Use of phosphate-binding agents is associated with a lower risk of mortality
Open Access
- 1 November 2013
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 84 (5) , 998-1008
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- COSMOS: the dialysis scenario of CKD–MBD in EuropeNephrology Dialysis Transplantation, 2012
- Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE InhibitionJournal of the American Society of Nephrology, 2011
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patientsNephrology Dialysis Transplantation, 2011
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJAMA, 2011
- Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES StudyNephrology Dialysis Transplantation, 2010
- Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis populationNephrology Dialysis Transplantation, 2010
- Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2Journal of Bone and Mineral Research, 2010
- Phosphorus Binders and Survival on HemodialysisJournal of the American Society of Nephrology, 2009
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing HemodialysisNew England Journal of Medicine, 2008
- Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patientsKidney International, 2007